Perak to stop issuing new vape licences, aiming for a phased “zero sales” outcome after October

Jan.05
Perak to stop issuing new vape licences, aiming for a phased “zero sales” outcome after October
Perak executive councillor Datuk Sivanesan said the state government aims to progressively reach a “zero” level of vape sales no later than after October, noting vape operators were clearly informed in October 2025.

Key Points

 

• Goal: Perak to phase toward “zero vape sales” no later than after October

• Licensing: no new vape sales licences issued by Perak local authorities from Jan. 1, 2026

• Transition: existing unexpired licences may continue operating until expiry

• Federal update: amendments to tobacco-control laws for a nationwide ban are being prepared and expected to be tabled soon; a gazetted national ban would override

• Enforcement: local authorities will act against businesses that continue selling after the ban takes effect

 


 

2Firsts, January 5, 2026, 14:04 – According to Oriental Daily, Perak executive councillor Datuk Sivanesan said the state government aims to progressively achieve a “zero” level of vape sales no later than after October, as vape operators had been clearly notified in October 2025.

 

He said that if the federal government completes legislative amendments and gazettes a nationwide ban on vape sales before then, the national law would take precedence and Perak’s transitional arrangements would no longer apply.

 

Sivanesan said the federal government has begun studying amendments to relevant tobacco-control laws to ban e-cigarettes nationwide. He said several countries, including India, China, Thailand and Singapore, have fully banned e-cigarettes, and added that the health minister’s stance is firm, with related research and legal review completed by the Attorney General’s Chambers, and that amendment documents are expected to be tabled in Parliament soon.

 

At a press conference, Sivanesan, who oversees Perak’s human resources, health, Indian community and national unity portfolios, said the Perak government passed a vape sales ban policy in October 2025 and moved at the state level amid growing concerns about youth access and misuse.

 

He said that as the federal government has not yet imposed a comprehensive ban, Perak has acted within its powers by stopping the issuance of new vape sales licences as a preventive and control measure.

 

He said police research showed some traders were abusing the current system by supplying substances unsuitable for vaping, posing health risks, with most affected being young people. He said vapes were readily available, including in shopping malls.

 

He said he had announced that from Jan. 1, 2026, all local authorities in Perak would no longer issue any new vape sales licences. Licences already issued and not yet expired may continue operating until they expire. He said the state must provide a reasonable transition period, noting that licences issued as late as December could remain valid for up to 11 months, requiring a gradual phase-out while monitoring federal amendment progress.

 

Asked what operators should do with remaining inventory after licences expire, Sivanesan said operators had been notified in October 2025 that licences would not be renewed and should have made arrangements in advance.

 

He said some vape companies had appealed to him over livelihood concerns, and that the state therefore provided enough time for operators to transition, with companies aware they cannot continue vape business after the transition ends. He also stressed the measures would not affect retail employees’ jobs and pay, citing convenience-store staff as general sales workers, and said employers cannot cut wages on that basis.

 

He said local authorities would take action in accordance with the law against any business that continues selling vapes after the ban takes effect.

 

Photo credit: Oriental Daily News

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | IVG Launches NEXiO Prefilled Pod System, Expanding Beyond Disposable Vapes
Product | IVG Launches NEXiO Prefilled Pod System, Expanding Beyond Disposable Vapes
UK vape brand IVG has launched the NEXiO reusable prefilled pod system, expanding its product portfolio beyond disposable vape products. The device features a 1,000mAh rechargeable battery, prefilled pods with a refill reservoir structure and a claimed capacity of up to 10,000 puffs. Officially launched in the UK on July 9, 2026, NEXiO debuted with 17 flavor options, reflecting IVG’s move into reusable pod formats.
Aug.19
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
Kumulus Vape2026 H1 Revenue Falls 8.3% but Profit Rises 24% as B2B Weakens and Consumer Channels Grow
French vaping company Kumulus Vape reported first-half 2026 revenue of €25.5 million, down 8.3% year over year, as its core B2B distribution business fell 11% to €21.6 million. B2C and store-network revenue rose 5.6% and 17.8%, respectively. Commercial margin increased to 26.3% from 21.7%, while net profit rose 24.1% to €0.8 million. The company attributed the profitability improvement to catalog optimization, logistics restructuring and the ramp-up of Labster, its in-house production unit for proprietary brands.
Market
Sep.17 by 2Firsts Perspectives
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
HM Revenue & Customs put the UK's Vaping Products Duty and Vaping Duty Stamps Scheme into effect on October 1. All vaping liquids manufactured in or imported into the UK are now subject to duty at £2.20 per 10ml, regardless of nicotine content. The stamp regime will introduce digital functionality designed to provide traceability throughout the supply chain, with approved manufacturers, importers and warehousekeepers required to report product movements and retailers and consumers eventually able to scan stamps to verify authenticity. China exported $177 million of vape-related products to the UK in August, up 51.4% year over year, increasing the significance of the new compliance regime for China's Shenzhen-centered vape supply chain.
Regulations
Oct.04
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives